Published in Glia on December 22, 2011
Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74
Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev (2013) 1.26
Candidate drug targets for prevention or modification of epilepsy. Annu Rev Pharmacol Toxicol (2014) 1.15
Neuronal transgene expression in dominant-negative SNARE mice. J Neurosci (2014) 1.14
Neuronal transporter and astrocytic ATP exocytosis underlie activity-dependent adenosine release in the hippocampus. J Physiol (2013) 1.05
Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology (2015) 0.92
Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options. J Inherit Metab Dis (2015) 0.90
What non-neuronal mechanisms should be studied to understand epileptic seizures? Adv Exp Med Biol (2014) 0.89
Presynaptic mechanisms of neuronal plasticity and their role in epilepsy. Front Cell Neurosci (2014) 0.86
Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? Front Cell Neurosci (2013) 0.86
Role of adenosine in status epilepticus: a potential new target? Epilepsia (2013) 0.84
Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development. Epilepsia (2015) 0.83
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front Mol Neurosci (2016) 0.82
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Mol Psychiatry (2014) 0.81
Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80
Purines released from astrocytes inhibit excitatory synaptic transmission in the ventral horn of the spinal cord. Front Neural Circuits (2014) 0.80
Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice. J Neurosurg (2013) 0.80
Glycine transporter 1 is a target for the treatment of epilepsy. Neuropharmacology (2015) 0.80
The role of glia in stress: polyamines and brain disorders. Psychiatr Clin North Am (2014) 0.80
Neurochemical measurement of adenosine in discrete brain regions of five strains of inbred mice. PLoS One (2014) 0.80
Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdala. Neuropharmacology (2013) 0.79
From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy. Epilepsia (2016) 0.79
Adenosinergic signaling in epilepsy. Neuropharmacology (2015) 0.78
Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain. J Sleep Res (2015) 0.77
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation. Psychopharmacology (Berl) (2015) 0.77
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy. Neurochem Res (2017) 0.76
Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis. J Neurochem (2017) 0.75
A scaffold as a platform for new therapies? Epilepsy Curr (2012) 0.75
Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus. J Pharmacol Exp Ther (2016) 0.75
Purines: forgotten mediators in traumatic brain injury. J Neurochem (2016) 0.75
Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol (2013) 0.75
Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential. Front Physiol (2015) 0.75
Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. J Clin Invest (2017) 0.75
Astrocytic purinergic signaling coordinates synaptic networks. Science (2005) 6.55
Adenosine receptors as therapeutic targets. Nat Rev Drug Discov (2006) 6.15
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16
Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol (2010) 3.38
The equilibrative nucleoside transporter family, SLC29. Pflugers Arch (2003) 3.00
Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis (2007) 2.81
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Connexin 43 hemichannels are permeable to ATP. J Neurosci (2008) 2.46
Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci (2004) 2.25
Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol (2005) 2.19
Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol (1992) 2.11
Methionine metabolism and liver disease. Annu Rev Nutr (2008) 1.98
Adenosine and brain function. Int Rev Neurobiol (2005) 1.97
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86
Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol (1980) 1.81
A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79
The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol (2007) 1.72
Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci U S A (2002) 1.70
Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials (2008) 1.57
The neurobiology of cognitive disorders in temporal lobe epilepsy. Nat Rev Neurol (2011) 1.54
Adenosine receptors and the central nervous system. Handb Exp Pharmacol (2009) 1.53
Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain (2007) 1.50
Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist (2005) 1.48
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A (2001) 1.47
Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience (2006) 1.46
Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol (2006) 1.40
Adenosine signaling and function in glial cells. Cell Death Differ (2009) 1.39
Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia (2008) 1.38
The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet Neurol (2008) 1.38
Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia (2003) 1.38
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab (2006) 1.37
Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb Exp Pharmacol (2009) 1.36
Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab (2006) 1.30
Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol (2007) 1.27
Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology (2008) 1.27
A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs. J Neurosci (2008) 1.27
Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience (2007) 1.25
Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci (2005) 1.25
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Top Med Chem (2005) 1.24
S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta (1994) 1.24
Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23
Mechanism of synthesis of adenine from hydrogen cyanide under possible primitive earth conditions. Nature (1961) 1.20
Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab (2007) 1.18
Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol (2009) 1.18
Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology (2008) 1.18
Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology (1994) 1.15
Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics (2009) 1.14
Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia (1980) 1.14
Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol (2005) 1.11
Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem (2005) 1.10
The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia (2011) 1.07
Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci (2008) 1.07
The role of mitochondria in epileptogenesis. Curr Opin Neurol (2002) 1.07
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia (1996) 1.05
Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia (2003) 1.03
Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett (2004) 1.02
Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus. Biochem Biophys Res Commun (2009) 1.01
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia (2011) 1.01
Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci (2007) 1.00
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Maximum activities, properties and distribution of 5' nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J Neurochem (1979) 0.99
Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery (1997) 0.97
Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia (2011) 0.97
Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol (1985) 0.96
Focally injected adenosine prevents seizures in the rat. Exp Neurol (2004) 0.95
Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab (2011) 0.95
Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis? Glia (2011) 0.91
Manipulation of adenosine kinase affects sleep regulation in mice. J Neurosci (2010) 0.91
A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods (1992) 0.90
Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem Int (1996) 0.89
Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res (1994) 0.88
What can adenosine neuromodulation do for neuroprotection? Curr Drug Targets CNS Neurol Disord (2005) 0.86
Distribution of adenosine deaminase activity in rat brain and spinal cord. J Neurosci (1986) 0.85
Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol (2010) 0.84
Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.84
Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci Lett (2000) 0.83
Mitochondrial disorders. J Child Neurol (2002) 0.83
Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res (2011) 0.81
Effect of inosine on seizures induced with pentylenetetrazole, bicuculline, or picrotoxin. Epilepsia (1985) 0.79
Can adenosine substitute for SAM-e as an adjunct in the treatment of depression? Med Hypotheses (2009) 0.76